Immune System News and Research

RSS

New Australian research shows how immune system avoids attacking own tissues with antibodies

New Australian research has shown how the immune system avoids attacking its own tissues with antibodies - whilst still maintaining a strong defence against invaders.

11 Nov 2016

NSU researchers learn more about Gulf War illness to help veterans

As the nation honors our veterans on November 11, we must pause to remember the long-lasting health effects soldiers experience not only from bullets or bombs, but from exposure to unexplained pesticides, radiation or other toxins during their time in the service.

11 Nov 2016

New study identifies novel target for treatment of Graves' disease and other scarring eye conditions

A new class of therapies may be on the horizon for thyroid eye disease (TED) and other destructive scarring conditions.

11 Nov 2016

Arthritis drug increases effectiveness of antidepressants in bipolar patients

Giving severely depressed patients the arthritis drug celecoxib (Celebrex) dramatically boosted the effectiveness of their antidepressant medication, a Loyola study has found.

10 Nov 2016

International consortium awarded $36.9 million grant to accelerate introduction of new typhoid vaccines

Typhoid fever, a bacterial infection that causes high fever and other disabling symptoms, remains a serious global problem in the developing world: it kills almost a quarter of a million people annually, and infects about 21 million.

10 Nov 2016

New research shows how synthetic DNA vaccine approach protects against Zika virus infection

As the global spread of the Zika virus continues, efforts are underway to halt the disease's transmission.

10 Nov 2016

Researchers exploring new platform for detecting pathogenic bacteria using bacteriophages

Bacterial pathogens pose serious health risks, especially for infants, young children, elderly and those with compromised immune systems.

10 Nov 2016

Experimental vaccine/immune stimulant combination may lead to viral remission in HIV patients

A study led by researchers at Beth Israel Deaconess Medical Center, in collaboration with scientists at Walter Reed Army Institute of Research, Janssen Vaccines & Prevention B.V., one of the Janssen Pharmaceutical Companies of Johnson & Johnson and Gilead Sciences, Inc., has demonstrated that combining an experimental vaccine with an innate immune stimulant may help lead to viral remission in people living with HIV.

9 Nov 2016

Ludwig study shows how experimental drug can reverse effects of suppressive immune cells

A Ludwig Cancer Research study shows that an experimental drug currently in clinical trials can reverse the effects of troublesome cells that prevent the body's immune system from attacking tumors.

9 Nov 2016

Investigational treatment combination improves virologic control in SIV-infected monkeys

Researchers have found that an investigational treatment combination of a therapeutic vaccine and an immune-stimulator improves virologic control and delays viral rebound following the discontinuation of antiretroviral therapy (ART) in non-human primates infected with SIV, the simian form of HIV.

9 Nov 2016

Certain anti-diabetic drugs can switch off molecule that plays key role in inflammatory diseases

A molecule thought to play a key role in some inflammatory diseases can be switched off by two widely used medicines, new research has shown.

9 Nov 2016

DNAtrix enters into license agreement with University of Florida to develop new oncolytic virus platform

DNAtrix, a clinical stage biotechnology company developing virus-driven immunotherapies for cancer, announced it has entered into an exclusive license agreement with the University of Florida, Gainesville to develop a novel oncolytic virus platform.

8 Nov 2016

SMU virologist receives NCI grant to advance research into how certain viruses cause cancers

SMU virologist and cancer researcher Robert L. Harrod has been awarded a $436,500 grant from the National Cancer Institute to further his lab's research into how certain viruses cause cancers in humans.

8 Nov 2016

Weight loss condition provides clues to why cancer immunotherapy may fail in many patients

A weight loss condition that affects patients with cancer has provided clues as to why cancer immunotherapy - a new approach to treating cancer by boosting a patient's immune system -- may fail in a substantial number of patients.

8 Nov 2016

New research explains how tumors may impair ability of the liver to respond to caloric deprivation

One of the worst cruelties of lethal cancer is the phenomenon called wasting, or in medical terms, cachexia (pronounced ka-CHEX-ia), in which a patient seems literally to diminish in bodily terms as the cancer ravages one or more internal organs.

8 Nov 2016

Caltech researchers develop new technique that increases safety of TCR gene therapy

The human body produces T cells to recognize and fight disease. Each T cell has a unique T cell receptor (or TCR) on its surface that surveils small fragments of proteins presented by other cells.

8 Nov 2016

Researchers develop new strategy to immunize against microbes that cause foodborne illness

University of California, Irvine and MIT researchers have developed a new strategy to immunize against microbes that invade the gastrointestinal tract, including Salmonella, which causes more foodborne illness in the United States than any other bacteria.

8 Nov 2016

Scientists develop new strategy to stop uncontrollable poison ivy itch

Scientists at Duke Health and Zhejiang Chinese Medical University have developed a strategy to stop the uncontrollable itch caused by urushiol, the oily sap common to poison ivy, poison sumac, poison oak and even mango trees.

7 Nov 2016

Scientists turn iron-scavenging power against common UTI-causing bacteria

For most invading bacteria, the bladder is not a friendly place. But for those that have figured out how to scavenge iron from their hosts, it's a fine place to grow and reproduce.

7 Nov 2016

Clinical study to test safety and ability of investigational Zika vaccine candidate begins

The first of five early stage clinical trials to test the safety and ability of an investigational Zika vaccine candidate called the Zika Purified Inactivated Virus (ZPIV) vaccine to generate an immune system response has begun at the Walter Reed Army Institute of Research Clinical Trial Center in Silver Spring, Maryland.

7 Nov 2016

Immune System News and Research

New Australian research shows how immune system avoids attacking own tissues with antibodies

NSU researchers learn more about Gulf War illness to help veterans

New study identifies novel target for treatment of Graves' disease and other scarring eye conditions

Arthritis drug increases effectiveness of antidepressants in bipolar patients

International consortium awarded $36.9 million grant to accelerate introduction of new typhoid vaccines

New research shows how synthetic DNA vaccine approach protects against Zika virus infection

Researchers exploring new platform for detecting pathogenic bacteria using bacteriophages

Experimental vaccine/immune stimulant combination may lead to viral remission in HIV patients

Ludwig study shows how experimental drug can reverse effects of suppressive immune cells

Investigational treatment combination improves virologic control in SIV-infected monkeys

Certain anti-diabetic drugs can switch off molecule that plays key role in inflammatory diseases

DNAtrix enters into license agreement with University of Florida to develop new oncolytic virus platform

SMU virologist receives NCI grant to advance research into how certain viruses cause cancers

Weight loss condition provides clues to why cancer immunotherapy may fail in many patients

New research explains how tumors may impair ability of the liver to respond to caloric deprivation

Caltech researchers develop new technique that increases safety of TCR gene therapy

Researchers develop new strategy to immunize against microbes that cause foodborne illness

Scientists develop new strategy to stop uncontrollable poison ivy itch

Scientists turn iron-scavenging power against common UTI-causing bacteria

Clinical study to test safety and ability of investigational Zika vaccine candidate begins

Immunology eBook

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News